Table 5. Magnitude of follow-up CD4 cell count by demographic and baseline treatment variables among patients on anti-retroviral therapy (N = 1,321).
Variable | Category | Total, n | Follow-up CD4 ≥350 | % with follow-up CD4≥350 | Chi square | P value |
---|---|---|---|---|---|---|
Age in years | 5–14 | 165 | 146 | 88.48 | 78.9601 | 0.000 |
>14 | 5076 | 2715 | 53.49 | |||
Gender | Female | 3330 | 2006 | 60.24 | 117.6648 | 0.000 |
Male | 1911 | 855 | 44.74 | |||
WHO Stage | I or II | 2079 | 1193 | 57.38 | 10.8558 | 0.001 |
III or IV | 3162 | 1668 | 52.75 | |||
Baseline CD4 cell count* | <100 | 1569 | 512 | 32.63 | 568.0106 | 0.000 |
100–199 | 2224 | 1253 | 56.34 | |||
200–349 | 1300 | 983 | 75.62 | |||
>349 | 148 | 113 | 76.35 |
* Measured in cells/mm3.